Companies / CYC

CYCLOPHARM LIMITED

ASX:CYCHealth Care Equipment & Services
126.1M shares on issueAppendix 2A · as of 20 Apr 2026$0.54price · delayed$70.4Mmarket cap · indicative
B
Dilution grade

Share count grew 16% in 24 months; 1 cash raise in 24 months

Cash runwayno data — not a quarterly (4C/5B) cash filer
Share-count growth (24m)16.4%
Raise cadence (24m)1 cash raise
Options & rights overhang0.0% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

CYCLOPHARM LIMITED's ordinary share count rose 16.4% between June 2024 and April 2026, to 126M shares. The company raised capital once in that period, with proceeds of A$14.2M recorded in January 2026. No proposed securities issues (Appendix 3B) are pending. The company does not have a current quarterly cash report on the record, so no quarterly cash balance or funding-runway figure is disclosed on that basis.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
0.0%
Max option dilution
0.0%
ITM option dilution
1
Raises · last 12 months
Cash cover · not a quarterly filer

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 126.1M per Appendix 2A (20 Apr 2026).
114.3M118.6M122.9MDec 24Sept 25July 26Cash raise · 30 Jan 2026

Cash runway

Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
6 July 20263H · cancellationCYC : ORDINARY FULLY PAID125.7MAppendix 3H
20 Apr 20262A · quoted issueCYC : ORDINARY FULLY PAID126.1MAppendix 2A
11 Mar 20262A · quoted issueCYC : ORDINARY FULLY PAID120.8MAppendix 2A
10 Feb 20262A · quoted issueCYC : ORDINARY FULLY PAID120.6MAppendix 2A
28 June 20242A · quoted issueCYC : ORDINARY FULLY PAID108.3MAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

1 cash raise in the last 24 months · 1 in the last 12 months

$14.2M
Capital raise
30 Jan 2026
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

No options or rights over unissued shares on record.

Director dealings

DateDirectorTypeSharesOptionsValueSource
12 Mar 2026Kevin Michael John BarrowBuy5k$5k3Y notice
12 Mar 2026James McBrayerBuy10$10k3Y notice
12 Mar 2026Dianne Margaret AngusBuy21k$20k3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.